Home > News > BioSante Pharmaceuticals Listed on Merrill Lynch
April 7th, 2004
BioSante Pharmaceuticals Listed on Merrill Lynch
BioSante Pharmaceuticals, Inc. announced today that the investment firms Merrill Lynch and Punk, Ziegel & Company have included BioSante in their respective indices of nanotechnology companies. "This is a key acknowledgment and validation of the important work we are doing with our calcium phosphate nanotechnology for drug delivery and vaccines," said Stephen M. Simes, president and chief executive officer of BioSante. "We are continuing to achieve important advances with this exclusive and innovative nanotechnology, which now appears to offer substantial potential for increasing stockholder value."
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013